Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 325 shares, a decrease of 57.0% from the July 15th total of 756 shares. Based on an average daily volume of 4,595 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are short sold.

Institutional Trading of Fidelity Disruptive Medicine ETF

A number of institutional investors have recently modified their holdings of FMED. Vise Technologies Inc. purchased a new position in Fidelity Disruptive Medicine ETF in the fourth quarter worth $234,000. Jane Street Group LLC increased its position in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after buying an additional 44,630 shares in the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Fidelity Disruptive Medicine ETF during the 4th quarter worth approximately $228,000.

Fidelity Disruptive Medicine ETF Price Performance

Shares of FMED stock traded up $0.10 during mid-day trading on Friday, hitting $30.22. The stock had a trading volume of 2,085 shares, compared to its average volume of 11,199. The firm has a market cap of $48.35 million, a PE ratio of 41.33 and a beta of 0.75. Fidelity Disruptive Medicine ETF has a fifty-two week low of $23.48 and a fifty-two week high of $30.54. The company’s 50-day simple moving average is $28.16 and its 200-day simple moving average is $26.26.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.